Clinical trials
Active, not recruiting Myeloproliferative Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 3 |
| PharmaEssentia | 3 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Eli Lilly and Company | 1 |
| Karyopharm Therapeutics Inc | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 12 |
| Primary Myelofibrosis | 6 |
| Myelodysplastic Syndromes | 4 |
| Thrombocythemia, Essential | 4 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Anemia | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Down Syndrome | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.